Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 USD | +0.94% | +0.62% | +113.25% |
Apr. 17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
Apr. 10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Hung
FOU | Founder | 66 | 18-03-19 |
Moses Makunje
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Dong Fang Liu
CTO | Chief Tech/Sci/R&D Officer | 54 | 22-07-17 |
Gary Hattersley
CTO | Chief Tech/Sci/R&D Officer | 57 | 19-05-31 |
David Hanley
PRN | Corporate Officer/Principal | 54 | 21-05-31 |
Stacy Markel
HRO | Human Resources Officer | 59 | 19-09-30 |
Kerry Wentworth
LAW | General Counsel | 51 | 22-07-17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Hung
FOU | Founder | 66 | 18-03-19 |
Kim Blickenstaff
BRD | Director/Board Member | 71 | 19-07-31 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 20-09-30 |
Daniel Welch
CHM | Chairman | 66 | 20-06-30 |
Robert D. Mashal
BRD | Director/Board Member | - | Jan. 07 |
Tony Vernon
BRD | Director/Board Member | 68 | 19-05-31 |
Director/Board Member | 56 | 20-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,000,000 | 0 | 0 | 75.17 % |
Stock B | 1 | 245,692,474 | 185,427,238 ( 75.47 %) | 0 | |
Stock C | 0 | 851,202 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.25% | 846M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- NUVB Stock
- Company Nuvation Bio Inc.